Glaucoma – Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData, the industry analysis specialist’s new report, “Glaucoma – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Glaucoma: Market Characterization
2.1 Overview
2.2 Glaucoma Market Size
2.3 Glaucoma Market Forecast and CAGR
2.4 Drivers and Barriers for the Glaucoma Market
2.4.1 Drivers of the Glaucoma Market
2.4.2 Barriers for the Glaucoma Market
2.5 Opportunity and Unmet Need
2.6 Key Takeaway
3 Glaucoma Market: Competitive Assessment
3.1 Overview
3.2 Strategic Competitor Assessment
3.2.1 Xalatan
3.2.2 Cosopt
3.2.3 Alphagan P
3.2.4 Travatan Z
3.2.5 Lumigan
3.3 Key Takeaway
4 Glaucoma: Pipeline Assessment
4.1 Overview
4.2 Strategic Pipeline Assessment
4.2.1 Technology Trends Analytic Framework
4.3 Glaucoma Therapeutics – Promising Drugs under Clinical Development.
4.4 Drugs under Clinical Development
4.4.1 Tafluprost (Saflutan)
4.4.2 NCX-116 (Formerly PF-03187207)
4.4.3 Catioprost
4.5 Glaucoma Therapeutics Market – Clinical Pipeline by Mechanism of Action
4.6 Glaucoma Pipeline – Pipeline by Phase of Clinical Development
4.6.1 Glaucoma Therapeutics – Phase III Clinical Pipeline
4.6.2 Glaucoma Therapeutics – Phase II Clinical Pipeline
4.6.3 Glaucoma Therapeutics – Phase I Clinical Pipeline
4.6.4 Glaucoma Therapeutics – Preclinical Pipeline
4.6.5 Glaucoma Therapeutics – Discovery Pipeline
4.7 Discontinued / Suspended Drugs for Glaucoma
4.8 Key Takeaway
5 Glaucoma Market: Implications for Future Market Competition
6 Glaucoma Market: Future Players in the Glaucoma Market
6.1 Introduction
6.2 NicOx SA and Bausch and Lomb
6.2.1 Overview
6.2.2 Business Description
6.2.3 Ophthalmology Portfolio
6.2.4 Glaucoma Product Portfolio
6.3 Novagali Pharma SA
6.3.1 Overview
6.3.2 Business Description
6.3.3 Glaucoma Product Portfolio
6.4 Merck (MSD) and Santen Pharmaceuticals, Japan
6.4.1 Overview
6.4.2 Business Description
6.4.3 Glaucoma Product Portfolio
7 Glaucoma Market: Appendix
7.1 Definitions
7.2 Acronyms
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasting
7.3.4 Primary Research
7.3.5 Expert Panels
7.4 Contact Us
7.5 Disclaimer
7.6 Sources
Buy Now : Market Research
Related Reports
- Head and Neck Cancer – Drug Pipeline Analysis and Market Forecasts to 2016
- Amyotrophic Lateral Sclerosis (Lou Gehrig’s) – Drug Pipeline Analysis and Market Forecasts to 2016
- Erectile Dysfunction – Drug Pipeline Analysis and Market Forecasts to 2016
- Tuberculosis – Drug Pipeline Analysis and Market Forecasts to 2016
- Hepatitis B – Drug Pipeline Analysis and Market Forecasts to 2016
- Candidiasis – Drug Pipeline Analysis and Market Forecasts to 2016
- Acne – Drug Pipeline Analysis and Market Forecasts to 2016
- Herpes Simplex – Drug Pipeline Analysis and Market Forecasts to 2016
- Stomach Cancer – Drug Pipeline Analysis and Market Forecasts to 2016
- Hepatitis C – Drug Pipeline Analysis and Market Forecasts to 2016
